Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Oct 2016 for ReShape Lifesciences Inc., €14k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew Norwood: trading record in brief
Only one filing by Matthew Norwood is known so far (12 October 2016): an open-market purchase, €14k, in ReShape Lifesciences Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew Norwood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 1,000 shares@ US$15.00100.0% of flowCommon StockSEC:0001209191-16-145723:0Canonical exit: 10 Jan 2017 (T+90)
1 of 1 declaration